Saurab Jain
@saurab.jain.2186
Thane
12+ Years of experience
SEBI Registration INH000012838
Trade Ideas
1k
Opinions
802
Followers
110k
Expertise
Quantitative
Growth
Technical
Index Strategies
Market Commentary
Futures & Options
Technical Analysis
Trade Facts
Total Trades
0
Missed Trades
0
Profit Trades
0
0%Accuracy
Ask me Anything
Got a question? Ask me and I will answer it. Stay curious, stay hungry!
Posts
shared an insight ⚡️ 29th Sep
ZYDUSLIFE Hits 2Year High, But Bearish Candle Raises Caution
Zydus Lifesciences touched ₹1,232.10, a two-year high, on September 29, 2026, before closing lower and ending a nine-session winning streak. Key levels: ₹1,232 resistance and ₹1,152 20-day SMA support.
Zydus Lifesciences (
ZYDUSLIFE
) touched ₹1,232.10 on September 29, 2026, marking a fresh two-year high, but the stock ended the session in the red. This also brought an end to its impressive nine-consecutive-session winning streak.
On the regulatory front, the USFDA completed a cGMP inspection of Zydus' SEZ II Ahmedabad facility from September 21–28, with one observation and no data-integrity-related observations.
Technically, the earlier resistance around ₹1,205 had been decisively crossed during the recent rally. However, after touching the new high, the price moved back toward this breakout zone, making ₹1,205 an important level to monitor.
Notably, today's price action formed a Bearish Engulfing candlestick pattern near the top. The day's range completely engulfed the previous session's range, indicating increased selling pressure after the sharp run-up.
Conclusion: The ₹1,232 zone now stands out as a key resistance, while the 20-day SMA near ₹1,152 may act as an important support level. The coming sessions will show whether the ₹1,205 breakout zone holds.
Disclosure: I do not hold any position or have any financial interest in the mentioned stock. shared an insight ⚡️ 29th Sep
Bliss GVS Pharma Hits Fresh ATH After ₹728 Breakout
Bliss GVS Pharma hits a fresh all-time high at ₹737.65 after breaking ₹728 resistance. The stock has gained around 347% in CY2026, reflecting strong momentum.
Bliss GVS Pharma Ltd. (
BLISSGVS
) hits a fresh all-time high at ₹737.65 after breaking ₹728 resistance. The stock has gained around 347% in CY2026, reflecting strong momentum.
Bliss GVS Pharma Ltd. remained in the spotlight after the stock hit the 5% upper circuit and closed at ₹737.65, gaining 4.68% or ₹32.95 in the session on 28 Sept 2026. The stock also marked a fresh all-time high, extending its price momentum.
From a technical perspective, the stock continues to display a strongly bullish trend. After a period of decent consolidation near the top, BLISSGVS broke above the key resistance zone of ₹728 and closed above that level, marking a notable breakout.
The stock's price performance in CY2026 has been particularly striking, with gains of around 347% so far.
Bliss GVS Pharma operates globally across 60+ countries and has a strong presence in pharmaceutical formulations, particularly suppositories and pessaries.
With the stock at ₹737.65, above its previous ₹728 resistance and at a fresh all-time high, BLISSGVS is currently witnessing a strong bull run. The breakout above ₹728 came after a period of consolidation, adding significance to the latest price move. The price action remains the key feature of the stock's current market setup.
Disclosure: I do not hold any position or have any financial interest in the mentioned stock. shared an insight ⚡️ 28th Sep
Manappuram Finance Falls 6%: Four-Day Winning Streak Snapped
Manappuram Finance falls over 6%, ending a four-day winning streak. ₹310 remains immediate support, while ₹335 is a key resistance level.
Manappuram Finance Ltd
MANAPPURAM
witnessed sharp selling pressure on September 28, 2026, falling over 6% and snapping its four-day winning streak. The decline comes after a recent recovery in the stock, while the broader trend continues to remain bullish.
From a technical perspective, ₹310 emerges as an immediate support level to watch. On the higher side, ₹335 may act as a key resistance zone in the near term. Price movement around these levels could provide a clearer indication of the stock’s next phase.
Despite the latest decline, Manappuram Finance remains around 18% below its all-time high recorded in July 2026. At the same time, the stock is still approximately 27% above its 52-week low recorded in March 2026, reflecting the wide trading range witnessed over the period.
The latest session marks a notable pause after four consecutive gaining sessions, bringing short-term volatility back into focus. Market participants may track the stock’s price action around the ₹310 support and ₹335 resistance levels while assessing how the broader trend develops.
Disclosure: I do not hold any position or have any financial interest in the mentioned stock.FAQ's
What are the top stock recommendations by Saurab Jain?
Saurab Jain regularly shares stock views and market analysis on StockGro. Some of the stocks they have recently shared views on include ZYDUSLIFE, BLISSGVS and MANAPPURAM. Explore Saurab Jain's complete list of posts and trade views on their StockGro profile.
How can I follow Saurab Jain's latest investment insights?
You can follow Saurab Jain's latest investment insights, stock recommendations, and market analysis on StockGro App. Additionally, you can check their detailed stock analysis reports in the StockGro blog section.
What is Saurab Jain's investment strategy?
Saurab Jain follows a data-driven, research-backed investment strategy focused on maximizing returns while managing risk. Their approach includes fundamental and technical analysis, portfolio diversification, and sectoral trends to identify high-potential stocks.
How long has Saurab Jain been a SEBI-registered Research Analyst (RA)?
Saurab Jain has been a SEBI-registered Research Analyst and have 12+ Years of experience. With extensive experience in stock market analysis and investment research, they have guided investors in making informed and profitable decisions.
Where can I see Saurab Jain's past performance and stock picks?
You can check Saurab Jain's past stock recommendations, success rate, and investment insights on their StockGro profile. Their historical stock picks reflect a track record of strategic investment decisions based on thorough research.
How can I contact Saurab Jain for stock market advice?
For stock market guidance from Saurab Jain, you can connect through their StockGro profile. Some RAs may also provide personalized investment consultations based on their availability and SEBI regulations.
What is Saurab Jain's track record in predicting market movements?
Saurab Jain has a proven track record of accurate market analysis and trend predictions. By analyzing economic indicators, market sentiment, and technical charts, they have consistently helped investors make well-timed investment decisions.
What is the SEBI Registration number for Saurab Jain?
Saurab Jain is a SEBI-registered Research Analyst with the SEBI Registration INH000012838. This ensures that their investment recommendations comply with SEBI's regulatory framework for investor protection and financial advisory standards.
Be Financially Free with StockGro